Skip to main navigation Skip to search Skip to main content

Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial

  • T.J. de Villiers
  • , A.A. Chines
  • , S. Palacios
  • , P.T.A.M. Lips
  • , A.Z. Sawicki
  • , A.B. Levine
  • , C. Codreanu
  • , N. Kelepouris
  • , J.P. Brown

Research output: Contribution to journalArticleAcademicpeer-review

64 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)567-576
JournalOsteoporosis international
Volume22
Issue number2
DOIs
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this